Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer
Những tác giả chính: | Rea, D, Gray, R, Bowden, S, Handley, K, Earl, H, Poole, C, Bates, T, Dewar, J, Raytor, Z, Lee, M |
---|---|
Định dạng: | Conference item |
Được phát hành: |
2013
|
Những quyển sách tương tự
-
Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study
Bằng: Dennis C. Sgroi, et al.
Được phát hành: (2022-12-01) -
An Extraordinary New Toad (Bufo) ttom Costa Rica
Bằng: Jay M Savage
Được phát hành: (2002-06-01) -
Tamoxifen-independent recombination in the RIP-CreER mouse.
Bằng: Yanmei Liu, et al.
Được phát hành: (2010-10-01) -
Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals
Bằng: Joonatan Palmu, et al.
Được phát hành: (2020-08-01) -
FGFR1 Is Associated With Tamoxifen Resistance and Poor Prognosis of ER-Positive Breast Cancers by Suppressing ER Protein Expression
Bằng: Qing Lv MD, PhD, et al.
Được phát hành: (2021-03-01)